Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosis

Multiple Sclerosis

Volumn 12, Issue 1, 2006, Pages 94-100

  Shinto, Lynne ^a   Yadav, V ^a,b   Morris, C ^c   Lapidus, J A ^c   Senders, A ^d   Bourdette, D ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d National College of Natural Medicine   (United States)

Author keywords

Complementary medicine; Health survey; Multiple sclerosis; Quality of life

Indexed keywords

5 HYDROXYTRYPTOPHAN; ALPHA TOCOPHEROL; ASCORBIC ACID; AYURVEDIC DRUG; BETA CAROTENE; BETA1A INTERFERON; BIOFLAVONOID; CARNITINE; CHINESE DRUG; COD LIVER OIL; CYANOCOBALAMIN; ESSENTIAL FATTY ACID; FISH OIL; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; HYPERICUM PERFORATUM EXTRACT; KAVA EXTRACT; MAGNESIUM; MELATONIN; PRASTERONE; PRIMROSE OIL; RETINOL; SELENIUM; THIOCTIC ACID; UBIDECARENONE; UNINDEXED DRUG; VALERIAN; VITAMIN B COMPLEX; ZINC;

ACADEMIC ACHIEVEMENT; ADULT; AEROBIC EXERCISE; AGE; ALTERNATIVE MEDICINE; ARTICLE; BEE STING; DEMOGRAPHY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENDER; GLUTEN FREE DIET; GUIDED IMAGERY; HEALTH CARE UTILIZATION; HEAVY METAL REMOVAL; HUMAN; HYPERBARIC OXYGEN; HYPNOSIS; LOW FAT DIET; MACROBIOTIC DIET; MAJOR CLINICAL STUDY; MALE; MEDITATION; MENTAL HEALTH; MULTIPLE SCLEROSIS; PLASMA TRANSFUSION; PLASMAPHERESIS; QUALITY OF LIFE; RACE; SELF REPORT; SEX DIFFERENCE; STRETCHING; SWIMMING; VEGETARIAN DIET; WALKING; WELLBEING; YOGA;

ADULT; ATTITUDE TO HEALTH; COMPLEMENTARY THERAPIES; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OREGON; SELF-HELP GROUPS; SEVERITY OF ILLNESS INDEX;

EID: 31644438191     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458506ms1230oa     Document Type: Article

References (24)

1. Berkman C, Pignotti M, Cavallo P, Holland N. Use of alternative treatments by people with multiple sclerosis. Neurorehabil Neural Rep 1999; 13: 243-54.
2. Schwartz CE, Laitin E, Brotman S, LaRocca N. Utilization of unconventional treatments by persons with MS: is it alternative or complementary? Neurology 1999; 52: 626-29.
3. Nayak S, Matheis RJ, Schoenberger NE, Shiflett SC. Use of unconventional therapies by individuals with multiple sclerosis. Clin Rehabil 2003; 17: 181-91.
4. Marrie RA, Hadjimichael O, Vollmer T. Predictors of alternative medicine use by multiple sclerosis patients. Mult Scler 2003; 9: 461-66.
5. Page SA, Verhoef MJ, Stebbins RA, Metz LM, Levy CL. The use of complementary and alternative therapies by people with multiple sclerosis. Chronic Dis Can 2003; 24: 75-79.
6. Stnifbergen AR, Harrison TC. Complementary and alternative therapy use in persons with multiple sclerosis. Rehabil Nurs 2003; 28: 141-47.
7. Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998; 279: 1548-53.
8. Nortvedt MW, Riise T. The use of quality of life measures in multiple sclerosis research. Mult Scler 2003; 9: 63-72.
9. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-33.
10. Vollmer TL, Hadjimichael O, Preiningerova J, Ni W, Buenconsejo J. Disability and treatment patterns of multiple sclerosis patients in United States: a comparison of veterans and nonveterans. J Rehabil Res Dev 2002; 39: 163-74.
11. Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler 1999; 5: 349-54.
12. Hosmer D, Lemeshow S. Applied logistic regression, second edition. Wiley series in probability and statistics. John Wiley and Sons, Inc., 2000: 147-56.
13. Gray CM, Tan AW, Pronk NP, O'Connor PJ. Complementary and alternative medicine use among health plan members. A cross-sectional survey. Eff Clin Pract 2002; 5: 17-22.
14. Ong CK, Petersen S, Bodeker GC, Stewart-Brown S. Health status of people using complementary and alternative medical practitioner services in 4 English counties. Am J Publ Health 2002; 92: 1653-56.
15. Bausell RB, Lee WL, Berman BM. Demographic and health-related correlates to visits to complementary and alternative medical providers. Med Care 2001; 39: 190-96.
16. Miller DM, Rudick RA, Baler M, Cutter G, Doughtery DS, Weinstock-Guttman B et al. Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Mutt Scler 2003; 9: 1-5.
17. Chang CH, Celia D, Fernandez O, Luque G, de Castro P, de Andres C et al. Quality of life in multiple sclerosis patients in Spain. Mutt Scler 2002; 8: 527-31.
18. Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology 1999; 53: 1098-103.
19. Jain N, Astin JA. Barriers to acceptance: an exploratory study of complementary/alternative medicine disuse. J Altern Complement Med 2001; 7: 689-96.
20. Nortvedt MW, Riise T, Myhr KM, Nyland HI. Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population. Med Care 2000; 38: 1022-28.
21. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1171-78
22. Schwartz CE, Vollmer T, Lee H. Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group. Neurology 1999; 52: 63-70.
23. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology 2003; 60: 31-36.
24. Filippini G, Munari L, Incorvaia B, Ebers GC, Polman C, D'Amico R et al. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 2003; 361: 545-52.